New Drug Ad Guidelines Unlikely to Satisfy. Theresa Agovino.
by Agovino, Theresa; ProQuest Information and Learning Company.
Series: SIRS Enduring Issues 2006Article 74Business. Publisher: Concord Monitor, 2005ISSN: 1522-3191;.Subject(s): Advertising -- Drugs | Deceptive advertising | Pharmaceutical industry | Prescription drugsDDC classification: 050 Summary: "The pharmaceutical industry unveiled new guidelines Tuesday [Aug. 2, 2005] for the consumer marketing of medicines, including pledges to educate doctors before beginning consumer campaigns and more clearly outline the risks involved in taking prescription drugs." (CONCORD MONITOR) The article reveals that the industry promises to "put off consumer advertising while doctors learn about drugs," citing the Vioxx incident where "ads pushed many patients who really didn't require the pricey drug to take it, potentially exposing them to dangerous side effects."| Item type | Current location | Call number | Status | Date due |
|---|---|---|---|---|
Books
|
High School - old - to delete | REF SIRS 2006 Business Article 74 (Browse shelf) | Available |
Browsing High School - old - to delete Shelves Close shelf browser
| No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | No cover image available | ||
| REF SIRS 2006 Business Article 73 Why Medical Malpractice Caps Are Wrong. | REF SIRS 2006 Business Article 74 FDA Races to Keep Up with Misleading Drug Ads. | REF SIRS 2006 Business Article 74 The Big Pill Pitch. | REF SIRS 2006 Business Article 74 New Drug Ad Guidelines Unlikely to Satisfy. | REF SIRS 2006 Business Article 75 Consumer Vertigo. | REF SIRS 2006 Business Article 76 Online Banking: Are You Ready?. | REF SIRS 2006 Business Article 77 Kids at Risk?. |
Articles Contained in SIRS Enduring Issues 2006.
Originally Published: New Drug Ad Guidelines Unlikely to Satisfy, Aug. 2, 2005; pp. n.p..
"The pharmaceutical industry unveiled new guidelines Tuesday [Aug. 2, 2005] for the consumer marketing of medicines, including pledges to educate doctors before beginning consumer campaigns and more clearly outline the risks involved in taking prescription drugs." (CONCORD MONITOR) The article reveals that the industry promises to "put off consumer advertising while doctors learn about drugs," citing the Vioxx incident where "ads pushed many patients who really didn't require the pricey drug to take it, potentially exposing them to dangerous side effects."
Records created from non-MARC resource.
There are no comments for this item.